6 suspended. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Suspended 6 |
| Phase 1 | 1 | Suspended 1 |
Follow Acute Myeloid Leukemia: new trials by email Literature Review of Acute Myeloid Leukemia trials Research Report on Acute Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE Dasatinib - Acute Myeloid Leukemia | Phase 2 | Suspended | Institut Paoli-Calmettes | 35 | 2024-05-22 | 2026-10-01 |
| Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia IBI188, Azacitidine, Decitabine - Acute Myeloid Leukemia | Phase 1 / Phase 2 | Suspended | Innovent Biologics (Suzhou) Co. Ltd. | 222 | 2020-09-25 | 2023-10-23 |
| Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation Enasidenib Mesylate - Acute Myeloid Leukemia | Phase 2 | Suspended | City of Hope Medical Center | 35 | 2019-12-23 | 2026-08-21 |
| Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients Oshadi D & Oshadi R;, salvage therapy cytosar and mitoxantrone - Acute Myeloid Leukemia, Lymphoid Leukemia | Phase 2 | Suspended | Oshadi Drug Administration | 15 | 2017-01-01 | 2018-04-18 |
| Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients AS101 - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Suspended | BioMAS Ltd | 12 | 2015-01-01 | 2015-02-10 |
| L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes L-Ascorbic Acid - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Suspended | Samsung Medical Center | 25 | 1998-05-01 | 2006-10-26 |
Leukemia, Myeloid, Acute (6) · Myelodysplastic Syndromes (2) · Leukemia, Lymphoid (1)
Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Leukemia (6) · Leukemia, Myeloid (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Bone Marrow Diseases (2) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
2-Propanol (1) · Antineoplastic Agents (1) · Ascorbic Acid (1) · Azacitidine (1) · Dasatinib (1) · Decitabine (1) · Mitoxantrone (1) · ammonium trichloro(dioxoethylene-O,O'-)tellurate (1) · enasidenib (1) · methanesulfonic acid (1)
BioMAS Ltd (1) · City of Hope Medical Center (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Institut Paoli-Calmettes (1) · Oshadi Drug Administration (1) · Samsung Medical Center (1)
China (1) · France (1) · Israel (1) · South Korea (1) · United States (1)
Amandeep Salhotra (1) · Moshe Gatt, MD (1) · Won Seog Kim, MD (1)